Latest news
Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma - PR NewswirePR Newswire · Mon, 10 Aug 2026 11:00:00 GMTFor advanced melanoma, Labcorp's test supports access to targeted therapies - Stock TitanStock Titan · Mon, 10 Aug 2026 11:00:00 GMTScholar Rock Announces FDA Review of Apitegromab Biologics License Application (BLA) for Spinal Muscular Atrophy (SMA) to Progress with Second Fill-Finish Facility; Approval Decision Anticipated by September 30, 2026 Action Date - BioSpaceBioSpace · Mon, 10 Aug 2026 02:16:42 GMTRiboX Therapeutics Announces FDA IND Clearance for RXIM002, the first Circular RNA-Based in vivo CAR Therapy for Autoimmune Cytopenias - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 07:46:00 GMTGRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test - PR NewswirePR Newswire · Fri, 07 Aug 2026 15:05:00 GMTReplimune Announces FDA Approval of Oncolytic Immunotherapy - OncodailyOncodaily · Fri, 07 Aug 2026 08:30:33 GMTLabcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 11:00:00 GMTFresenius Announces FDA Approval of Rituximab Biosimilar for the U.S. Market - Business WireBusiness Wire · Mon, 03 Aug 2026 20:09:00 GMT